Fetal DNA test, or Non-Invasive Prenatal Test (NIPT), is a screening test that analyzes fetal DNA fragments present in the mother's blood to assess the risk of certain genetic abnormalities in the baby. This test is used to determine the risk of chromosomal abnormalities such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13). It can also provide information about sex chromosome abnormalities (such as Turner syndrome and Klinefelter syndrome) and some other genetic syndromes.
Fetal DNA testing is a safe and sensitive screening method that can be performed in the early stages of pregnancy. Since it is conducted using the mother's blood, it poses no risk to the baby. Therefore, it is referred to as "non-invasive."
TR Türkçe
EN English